Form 4 for LGVN Longeveron Inc.
Accepted 2024-05-06 00:00:00 ET · period of report 2024-05-02 · accession 0001214659-24-008444 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-06 | 2024-05-02 | LGVN | Agafonova Nataliya | Chief Medical Off | F - Tax | $2.83 | -308 | 1,771 | -15% | -$871.64 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-05-02 | F | D | 308 | $2.83 | 1,771 | D | — | — | (F1) Amounts reflect the one-for-ten reverse stock split undertaken by Issuer in April 2024. |